Vitiligo: what it is and how it is treated

Vitiligo is an autoimmune condition in which the immune system attacks the skin's pigment-producing cells, leaving white patches that can appear anywhere and may slowly spread. It is not contagious or dangerous to physical health, but it can be deeply affecting, and treatment aims both to halt progression and to restore color.

The mainstays work on the immune process and on stimulating repigmentation. Topical anti-inflammatory and immune-modulating creams can calm the local immune attack and encourage pigment return, especially on the face. Phototherapy, controlled ultraviolet light, particularly narrowband UVB, is a cornerstone for more widespread vitiligo, prompting surviving pigment cells to repopulate the patches over many sessions. In stable cases, surgical pigment-transfer techniques can be options. Newer targeted treatments aimed at the specific immune signals driving vitiligo have expanded the toolkit considerably.

Results vary by location and how long a patch has been present; the face responds best, hands and feet least. Early treatment tends to do better, and combining approaches (for instance phototherapy with topicals) often outperforms any single one. The key message is that vitiligo is treatable, increasingly so, and that a dermatologist can build a plan to slow its spread and bring color back, but it requires patience measured in months.